Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Drug Research
Drug Discovery & Development
Return to: PBR Home | Drug Research | Drug Discovery & Development | News
Search Refinements

Drug Discovery & Development News

View news from other Pharmaceutical sectors:
46-60 of 4442 results
Lyndra secures $23m funding to develop therapeutic oral delivery platform
Lyndra has secured $23m Series A financing, led by Polaris Partners, with participation from Quark Venture and GF Securities, Yonghua Capital, Healthlink Capital, Suffolk Equity, Partners Healthcare among others.
Drug Research > Drug Discovery & Development > News
BioCryst to explore BCX7353 use in acute HAE attacks
BioCryst Pharmaceuticals revealed its plans to explore a new oral liquid formulation of BCX7353 for the treatment of acute attacks in hereditary angioedema (HAE) patients.
Drug Research > Drug Discovery & Development > News
PureTech Health launches new immuno-oncology programme
PureTech Health has launched a new immuno-oncology programme to develop monoclonal antibodies to target newly discovered immunosuppressive mechanisms in pancreatic cancer and other solid tumours.
Drug Research > Drug Discovery & Development > News
Single dose of live-attenuated Zika vaccine found to protect mice
By PBR Staff Writer
New research has revealed that a single dose of the first live-attenuated Zika vaccine has been found to protect mice against the virus.
Drug Research > Drug Discovery & Development > News
Takeda, NuBiyota to collaborate on microbiome therapeutics
Takeda Pharmaceutical has partnered with NuBiyota to develop Microbial Ecosystem Therapeutic products for gastroenterology (GI) conditions.
Drug Research > Drug Discovery & Development > News
Immune-Onc to partner with University of Texas on novel cancer immunotherapy
Immune-Onc Therapeutics has signed an exclusive license and collaboration agreement with The University of Texas Health Science Center at Houston (“UTHealth”) and The University of Texas Southwestern Medical Center (“UTSW”), two member institutions of The University of Texas System (“UT System”).
Drug Research > Drug Discovery & Development > News
Eisai and Meiji enter into agreement for Parkinson's disease drug in Asian countries
Eisai and Meiji Seika Pharma have entered into a license agreement for the commercialization of safinamide for Parkinson's disease treatment in Japan and Asia.
Drug Research > Drug Discovery & Development > News
Finch and Takeda to jointly develop microbiome therapeutics in IBD
Microbiome engineering company, Finch Therapeutics and Takeda Pharmaceutical have reached a global collaboration agreement for the joint development of FIN-524.
Drug Research > Drug Discovery & Development > News
Aviragen Therapeutics to explore strategic alternatives
Aviragen Therapeutics intends to explore a range of strategic alternatives including a business combination, merger, in-licensing of complementary products, acquisition or any other value-building transaction.
Drug Research > Drug Discovery & Development > News
Sucampo Pharmaceuticals buys rare disease firm Vtesse
Sucampo Pharmaceuticals has acquired rare disease company Vtesse for upfront consideration of $200m.
Drug Research > Drug Discovery & Development > News
Verona Pharma announces new collaborations to develop dry powder and MDI formulations for COPD
Verona Pharma has announced new collaborations with two European technology companies to develop its first-in-class product candidate RPL554 as dry powder inhaler (DPI) and metered dose inhaler (MDI) formulations for maintenance treatment of chronic obstructive pulmonary disease (COPD).
Drug Research > Drug Discovery & Development > News
Warp Drive Bio forms technology alliance with GSK
Warp Drive Bio has partnered with GSK to discover potential therapeutics in oncology and other diseases.
Drug Research > Drug Discovery & Development > News
University of Dundee secures grant to discover new antibacterial drugs
University of Dundee in the UK has been awarded almost £1m to boost efforts to identify new new antibiotics to tackle bacterial infections.
Drug Research > Drug Discovery & Development > News
Ignyta to explore strategic options for cancer candidate taladegib
Ignyta is exploring strategic options for taladegib and has entered into an amended and restated license, development and commercialization agreement with Eli Lilly and Company for the taladegib oncology program.
Drug Research > Drug Discovery & Development > News
BioLineRx acquires UK cancer immunotherapeutics company Agalimmune
Clinical-stage biopharmaceutical firm BioLineRx has purchased Agalimmune, a private UK-based company with an anti-cancer immunotherapy platform.
Drug Research > Drug Discovery & Development > News
46-60 of 4442 results